NCT03696394View on ClinicalTrials.gov

A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 29, 2019

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2023

Conditions
Osteochondral Defect
Interventions
DEVICE

BioCartilage® Micronized Cartilage Matrix

BioCartilage® is a scaffold with Collagen Type II and cartilage matrix elements

Trial Locations (1)

V6Z 1Y6

RECRUITING

St. Paul's Hospital, Vancouver

Sponsors

Collaborators (1)

Arthrex, Inc.
All Listed Sponsors
collaborator

Arthrex, Inc.

INDUSTRY

lead

St. Paul's Hospital, Canada

OTHER

NCT03696394 - A Study to Evaluate the Efficacy of BioCartilage® Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects | Biotech Hunter | Biotech Hunter